Intec’s late-stage Parkinson’s study fails to meet endpoints – Drug Development Technology

Intec’s late-stage Parkinson’s study fails to meet endpoints – Drug Development Technology
Intec's late-stage Parkinson's study fails to meet endpoints  Drug Development TechnologyIntec Pharma has reported top-line results from the ACCORDANCE study of its Accordion Pill-Carbidopa/Levodopa to treat symptoms of Parkinson's. ... read more
Source: Google NewsPublished on 2019-07-22